The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.57BCNY
985.37M · vs all stocks (USD)
Updated Nov 19, 2026
Revenue (TTM)
2.22BCNY
332.96M · vs all stocks (USD)
Updated Nov 19, 2026
Profit Margin
-7.90%
Updated Nov 19, 2026
Beta
0.5090x
vs all stocks
Updated Nov 19, 2026
52-Week Change
-39.98%
vs all stocks
Updated Nov 19, 2026
Market Capitalization
6.57BCNY
985.37M · vs all stocks (USD)
Updated Nov 19, 2026
Enterprise Value
6.86BCNY
1.03B · vs all stocks (USD)
Updated Nov 19, 2026
Forward P/E
21.72x
Updated Nov 19, 2026
Price to Sales (TTM)
2.89x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 2.96×.Updated Nov 19, 2026
Price to Book (MRQ)
0.6980x
Updated Nov 19, 2026
Enterprise to Revenue
3.09x
Updated Nov 19, 2026
Enterprise to EBITDA
-18.44x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 15.52×.Updated Nov 19, 2026
Gross Margin
61.28%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 63.68%.Updated Nov 19, 2026
Profit Margin
-7.90%
Updated Nov 19, 2026
Operating Margin
-11.36%
Updated Nov 19, 2026
Return on Assets (TTM)
-1.45%
Updated Nov 19, 2026
Return on Equity (TTM)
-1.91%
Updated Nov 19, 2026
Revenue (TTM)
2.22BCNY
332.96M · vs all stocks (USD)
Updated Nov 19, 2026
Revenue per Share (TTM)
1.88CNYUpdated Nov 19, 2026
Quarterly Revenue Growth
-18.90%
Updated Nov 19, 2026
Gross Profit (TTM)
1.41BCNY
212.03M · vs all stocks (USD)
Updated Nov 19, 2026
EBITDA (TTM)
441.92MCNY
66.28M · vs all stocks (USD)
Updated Nov 19, 2026
Net Income (TTM)
-175.39MCNY
-26.31M · vs all stocks (USD)
Updated Nov 19, 2026
Quarterly Earnings Growth (YoY)
-34.72%
Updated Nov 19, 2026
Operating Cash Flow (TTM)
-4.88MCNY
-731.50K · vs all stocks (USD)
Updated Nov 19, 2026
Levered Free Cash Flow (TTM)
-163.68MCNY
-24.55M · vs all stocks (USD)
Updated Nov 19, 2026
5-Year Average Dividend Yield
0.14%
vs all stocks
Updated Nov 19, 2026
Payout Ratio
50.89%
Updated Nov 19, 2026
Minority Interest (Equity)
2.25MCNYFY2025 · Dec 31, 2025
Revenue
2.57BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
866.68MCNYFY2025 · Dec 31, 2025
Gross Profit
1.71BCNYFY2025 · Dec 31, 2025
Operating Income
102.71MCNY
15.41M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
30.68MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-42.90MCNYFY2025 · Dec 31, 2025
Net Income
73.58MCNYFY2025 · Dec 31, 2025
EBIT
36.48MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
441.92MCNYFY2025 · Dec 31, 2025
Research & Development
605.24MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
344.00MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
24.44MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
3.27MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
5.80MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0643CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0643CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
1.15BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
1.15BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
73.58MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
642.27KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-302.87MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-593.20MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
532.69MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
73.58MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
13.49MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-381.59MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-8.35MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-290.33MCNYFY2025 · Dec 31, 2025
Sale of Investments
25.83MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-264.49MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
180.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-180.00MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-24.62MCNYFY2025 · Dec 31, 2025
Other Financing Charges
14.14MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-10.48MCNYFY2025 · Dec 31, 2025
Shares Outstanding
1.18BSharesUpdated Nov 19, 2026
Float Shares
1.01BSharesUpdated Nov 19, 2026
% Held by Insiders
13.64%
vs all stocks
Updated Nov 19, 2026
% Held by Institutions
1.99%
vs all stocks
Updated Nov 19, 2026
Total Cash (MRQ)
194.09MCNY
29.11M · vs all stocks (USD)
Updated Nov 19, 2026
Total Cash per Share (MRQ)
0.1660CNYUpdated Nov 19, 2026
Total Debt (MRQ)
605.94MCNY
90.88M · vs all stocks (USD)
Updated Nov 19, 2026
Total Debt to Equity (MRQ)
0.0667x
Updated Nov 19, 2026
Current Ratio (MRQ)
2.06x
Updated Nov 19, 2026
Book Value per Share (MRQ)
7.78CNYUpdated Nov 19, 2026
Total Assets
11.23BCNY
1.68B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
4.03BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.60BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
7.19BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
87.84MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.51BCNYFY2025 · Dec 31, 2025
Cash
534.13MCNYFY2025 · Dec 31, 2025
Cash Equivalents
17.39MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
551.52MCNYFY2025 · Dec 31, 2025
Accounts Receivable
2.67BCNYFY2025 · Dec 31, 2025
Inventory
390.24MCNYFY2025 · Dec 31, 2025
Accounts Payable
907.93MCNYFY2025 · Dec 31, 2025
Short-term Debt
33.20MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
6.86MCNYFY2025 · Dec 31, 2025
Long-term Debt
60.57MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
1.18BCNYFY2025 · Dec 31, 2025
Retained Earnings
2.54BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
9.63BCNY
1.44B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
325.59MCNYFY2025 · Dec 31, 2025
52-Week Low
5.11CNYUpdated Nov 19, 2026
52-Week High
10.77CNYUpdated Nov 19, 2026
52-Week Change
-39.98%
vs all stocks
Updated Nov 19, 2026
Beta
0.5090x
vs all stocks
Updated Nov 19, 2026
50-Day MA
6.79CNYUpdated Nov 19, 2026
200-Day MA
7.01CNYUpdated Nov 19, 2026
Avg 10-Day Volume
49.37MSharesUpdated Nov 19, 2026
Avg 30-Day Volume
89.81MSharesUpdated Nov 19, 2026
Diluted EPS (TTM)
-0.1400CNYUpdated Nov 19, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Almost nothing is lost between its operating profit and its net income.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.61Profit Margin: -0.08
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -2.17
Altman Z-Score 3.29: safe zoneNotable
Altman Z-Score: 3.29
Supply Chain
Downstream position: depends on 18 industries, supplies 6Notable
Outgoing: 6.00Incoming: 18.00
High connectivity hub: 24 industry connectionsNotable
Total Connections: 24.00
Companies that share the same coordination system — how they create, deliver, or capture value.